De Clercq E - Search Results

1

Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase.

Liekens S, Bilsen F, De Clercq E, Priego EM, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. Liekens S, et al. Among authors: de clercq e. FEBS Lett. 2002 Jan 2;510(1-2):83-8. doi: 10.1016/s0014-5793(01)03233-1. FEBS Lett. 2002. PMID: 11755536 Free article.

2

A mercapto analogue of 5'-noraristeromycin.

Das SR, Schneller SW, Balzarini J, De Clercq E. Das SR, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Feb;10(2):457-60. doi: 10.1016/s0968-0896(01)00271-1. Bioorg Med Chem. 2002. PMID: 11741794

3

Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.

Sienaert R, Naesens L, Brancale A, De Clercq E, McGuigan C, Balzarini J. Sienaert R, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):249-54. doi: 10.1124/mol.61.2.249. Mol Pharmacol. 2002. PMID: 11809847

4

Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.

Auwerx J, North TW, Preston BD, Klarmann GJ, De Clercq E, Balzarini J. Auwerx J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):400-6. doi: 10.1124/mol.61.2.400. Mol Pharmacol. 2002. PMID: 11809865

5

6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.

Holý A, Votruba I, Masojídková M, Andrei G, Snoeck R, Naesens L, De Clercq E, Balzarini J. Holý A, et al. Among authors: de clercq e. J Med Chem. 2002 Apr 25;45(9):1918-29. doi: 10.1021/jm011095y. J Med Chem. 2002. PMID: 11960502

6

Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

Balzarini J, Sienaert R, Liekens S, Van Kuilenburg A, Carangio A, Esnouf R, De Clercq E, McGuigan C. Balzarini J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 May;61(5):1140-5. doi: 10.1124/mol.61.5.1140. Mol Pharmacol. 2002. PMID: 11961132

7

Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues.

Nieto MI, Caamaño O, Fernández F, Gómez M, Balzarini J, De Clercq E. Nieto MI, et al. Among authors: de clercq e. Nucleosides Nucleotides Nucleic Acids. 2002;21(3):243-55. doi: 10.1081/NCN-120003289. Nucleosides Nucleotides Nucleic Acids. 2002. PMID: 11991165

8

The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.

Balzarini J, Liekens S, Esnouf R, De Clercq E. Balzarini J, et al. Among authors: de clercq e. Biochemistry. 2002 May 21;41(20):6517-24. doi: 10.1021/bi0255930. Biochemistry. 2002. PMID: 12009916

9

Synthesis of 3' '-substituted TSAO derivatives with anti-HIV-1 and anti-HIV-2 activity through an efficient palladium-catalyzed cross-coupling approach.

Lobatón E, Rodríguez-Barrios F, Gago F, Pérez-Pérez MJ, De Clercq E, Balzarini J, Camarasa MJ, Velázquez S. Lobatón E, et al. Among authors: de clercq e. J Med Chem. 2002 Aug 29;45(18):3934-45. doi: 10.1021/jm020820h. J Med Chem. 2002. PMID: 12190315

10

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

Hatse S, Princen K, Bridger G, De Clercq E, Schols D. Hatse S, et al. Among authors: de clercq e. FEBS Lett. 2002 Sep 11;527(1-3):255-62. doi: 10.1016/s0014-5793(02)03143-5. FEBS Lett. 2002. PMID: 12220670 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,294 results

Search Page

Filters